Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

New advances in the diagnosis and treatment of autoimmune lymphoproliferative syndrome.

Teachey DT.

Curr Opin Pediatr. 2012 Feb;24(1):1-8. doi: 10.1097/MOP.0b013e32834ea739. Review.

2.

Optimal Management of Autoimmune Lymphoproliferative Syndrome in Children.

George LA, Teachey DT.

Paediatr Drugs. 2016 Aug;18(4):261-72. doi: 10.1007/s40272-016-0175-3. Review.

PMID:
27139496
3.

Autoimmune lymphoproliferative syndrome: an update and review of the literature.

Shah S, Wu E, Rao VK, Tarrant TK.

Curr Allergy Asthma Rep. 2014 Sep;14(9):462. doi: 10.1007/s11882-014-0462-4. Review.

4.

[Advances in the knowledge and management of autoimmune lymphoproliferative syndrome].

Garrido Colino C.

An Pediatr (Barc). 2014 Feb;80(2):122.e1-7. doi: 10.1016/j.anpedi.2013.06.004. Epub 2013 Sep 20. Review. Spanish.

5.

Autoimmune Lymphoproliferative Syndrome.

Bleesing JJH, Johnson J, Zhang K.

In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Ledbetter N, Mefford HC, Smith RJH, Stephens K, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2017.
2006 Sep 14 [updated 2014 Sep 11].

6.

Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS).

Teachey DT, Seif AE, Grupp SA.

Br J Haematol. 2010 Jan;148(2):205-16. doi: 10.1111/j.1365-2141.2009.07991.x. Epub 2009 Nov 23. Review.

7.

Autoimmune lymphoproliferative syndrome due to somatic FAS mutation (ALPS-sFAS) combined with a germline caspase-10 (CASP10) variation.

Martínez-Feito A, Melero J, Mora-Díaz S, Rodríguez-Vigil C, Elduayen R, González-Granado LI, Pérez-Méndez D, Sánchez-Zapardiel E, Ruiz-García R, Menchén M, Díaz-Madroñero J, Paz-Artal E, Del Orbe-Barreto R, Riñón M, Allende LM.

Immunobiology. 2016 Jan;221(1):40-7. doi: 10.1016/j.imbio.2015.08.004. Epub 2015 Aug 17.

PMID:
26323380
8.

Advances in autoimmune lymphoproliferative syndromes.

Madkaikar M, Mhatre S, Gupta M, Ghosh K.

Eur J Haematol. 2011 Jul;87(1):1-9. doi: 10.1111/j.1600-0609.2011.01617.x. Review.

PMID:
21447005
9.

Updated Understanding of Autoimmune Lymphoproliferative Syndrome (ALPS).

Li P, Huang P, Yang Y, Hao M, Peng H, Li F.

Clin Rev Allergy Immunol. 2016 Feb;50(1):55-63. doi: 10.1007/s12016-015-8466-y. Review.

PMID:
25663566
10.

FAS haploinsufficiency is a common disease mechanism in the human autoimmune lymphoproliferative syndrome.

Kuehn HS, Caminha I, Niemela JE, Rao VK, Davis J, Fleisher TA, Oliveira JB.

J Immunol. 2011 May 15;186(10):6035-43. doi: 10.4049/jimmunol.1100021. Epub 2011 Apr 13.

11.

Identification of new Fas mutations in a patient with autoimmune lymphoproliferative syndrome (ALPS) and eosinophilia.

Aspinall AI, Pinto A, Auer IA, Bridges P, Luider J, Dimnik L, Patel KD, Jorgenson K, Woodman RC.

Blood Cells Mol Dis. 1999 Jun-Aug;25(3-4):227-38.

PMID:
10575548
12.

Diagnosis of autoimmune lymphoproliferative syndrome caused by FAS deficiency in adults.

Lambotte O, Neven B, Galicier L, Magerus-Chatinet A, Schleinitz N, Hermine O, Meyts I, Picard C, Godeau B, Fischer A, Rieux-Laucat F.

Haematologica. 2013 Mar;98(3):389-92. doi: 10.3324/haematol.2012.067488. Epub 2012 Sep 14.

13.

Mycophenolate mofetil as an alternate immunosuppressor for autoimmune lymphoproliferative syndrome.

Kossiva L, Theodoridou M, Mostrou G, Vrachnou E, Le Deist F, Rieux-Laucat F, Kanariou MG.

J Pediatr Hematol Oncol. 2006 Dec;28(12):824-6.

PMID:
17164652
14.

Rapid regression of lymphadenopathy upon rapamycin treatment in a child with autoimmune lymphoproliferative syndrome.

Janić MD, Brasanac CD, Janković JS, Dokmanović BL, Krstovski RN, Kraguljac Kurtović JN.

Pediatr Blood Cancer. 2009 Dec;53(6):1117-9. doi: 10.1002/pbc.22151.

PMID:
19588524
15.

Rapamycin improves lymphoproliferative disease in murine autoimmune lymphoproliferative syndrome (ALPS).

Teachey DT, Obzut DA, Axsom K, Choi JK, Goldsmith KC, Hall J, Hulitt J, Manno CS, Maris JM, Rhodin N, Sullivan KE, Brown VI, Grupp SA.

Blood. 2006 Sep 15;108(6):1965-71. Epub 2006 Jun 6.

16.

Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations.

Price S, Shaw PA, Seitz A, Joshi G, Davis J, Niemela JE, Perkins K, Hornung RL, Folio L, Rosenberg PS, Puck JM, Hsu AP, Lo B, Pittaluga S, Jaffe ES, Fleisher TA, Rao VK, Lenardo MJ.

Blood. 2014 Mar 27;123(13):1989-99. doi: 10.1182/blood-2013-10-535393. Epub 2014 Jan 7.

17.

Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis.

Sneller MC, Wang J, Dale JK, Strober W, Middelton LA, Choi Y, Fleisher TA, Lim MS, Jaffe ES, Puck JM, Lenardo MJ, Straus SE.

Blood. 1997 Feb 15;89(4):1341-8.

18.

Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome.

Dowdell KC, Niemela JE, Price S, Davis J, Hornung RL, Oliveira JB, Puck JM, Jaffe ES, Pittaluga S, Cohen JI, Fleisher TA, Rao VK.

Blood. 2010 Jun 24;115(25):5164-9. doi: 10.1182/blood-2010-01-263145. Epub 2010 Apr 1.

19.

Autoimmune lymphoproliferative syndrome due to FAS mutations outside the signal-transducing death domain: molecular mechanisms and clinical penetrance.

Hsu AP, Dowdell KC, Davis J, Niemela JE, Anderson SM, Shaw PA, Rao VK, Puck JM.

Genet Med. 2012 Jan;14(1):81-9. doi: 10.1038/gim.0b013e3182310b7d. Epub 2011 Oct 7.

PMID:
22237435
20.

Mutation of FAS, XIAP, and UNC13D genes in a patient with a complex lymphoproliferative phenotype.

Boggio E, Aricò M, Melensi M, Dianzani I, Ramenghi U, Dianzani U, Chiocchetti A.

Pediatrics. 2013 Oct;132(4):e1052-8. doi: 10.1542/peds.2012-1838. Epub 2013 Sep 16.

Supplemental Content

Support Center